Integra lifesciences
Integra LifeSciences Corporation, headquartered in the United States, is a prominent player in the health and social work services industry, specifically focusing on advanced medical technologies. Founded in 1989, the company has achieved significant milestones, including the development of innovative solutions in neurosurgery, orthopaedics, and regenerative medicine.
Integra's core offerings include a diverse range of products such as surgical instruments, wound care solutions, and tissue regeneration technologies. What sets Integra apart is its commitment to enhancing patient outcomes through cutting-edge research and development. With a strong market position, the company has garnered recognition for its contributions to improving surgical procedures and patient care, solidifying its reputation as a leader in the healthcare sector.
+4 vs industry average
Integra lifesciences’s score of 26 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Integra lifesciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Integra lifesciences's reported carbon emissions
Integra LifeSciences, a US-based company in the Health and social work services industry (85), reported a total of approximately 119.7 billion kg CO2e in emissions for the reporting year 2024. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions. For the 2024 reporting year, Scope 1 emissions were approximately 14.6 million kg CO2e, and Scope 2 emissions amounted to approximately 11.9 million kg CO2e. Scope 3 emissions were significantly higher, totalling approximately 96.2 million kg CO2e. The previous year, 2023, saw total emissions of approximately 180.3 million kg CO2e, with Scope 1 at about 8.3 million kg CO2e, Scope 2 at approximately 15.3 million kg CO2e, and Scope 3 at around 156.7 million kg CO2e. In 2022, total emissions were approximately 188.4 million kg CO2e, consisting of Scope 1 emissions of about 13.2 million kg CO2e, Scope 2 emissions of approximately 16.2 million kg CO2e, and Scope 3 emissions of approximately 159.0 million kg CO2e. In 2021, total emissions were approximately 191.5 million kg CO2e, with Scope 1 at about 13.9 million kg CO2e and Scope 2 at approximately 18.6 million kg CO2e. Scope 3 emissions were not reported for 2021. Integra LifeSciences has not publicly disclosed specific reduction targets or achievements in the provided data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Integra lifesciences’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Integra lifesciences yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Integra lifesciences
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project